Stratifying body mass index categories by waist circumference thresholds improves mortality risk prediction in postmenopausal women.

While a healthy lifestyle naturally has important benefits, yet seeking weight loss alone might not give an adequate picture ...

Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

HealthDay News — The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than traditional body mass index (BMI), according to a study published ...

• Future studies should report their results by age, gender, race/ethnicity; include the full data; include adverse events and other outcomes; control for both diet and physical activity in their ...

Rhythm said results of the recent trial were also consistent with BMI reductions achieved with setmelanotide therapy in similar patient populations in past trials. Setmelanotide, an existing ...

Rhythm Pharmaceuticals' experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said on Monday, sending its shares 24% higher in ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

More than 100 million Americans who qualify as overweight could see themselves tip into the obese category under newly ...

As per a prospective cohort study, waist circumference along with BMI modestly improves the prediction of which postmenopausal women are at a higher risk for premature death.